-
Oligo (dT) 25 Beads: Practical Guide for Eukaryotic mRNA Iso
2026-05-23
Oligo (dT) 25 Beads enable rapid, high-purity isolation of eukaryotic mRNA from total RNA or cell/tissue lysates, streamlining workflows such as RT-PCR and next-generation sequencing. They should be chosen for polyA tail mRNA capture in animal or plant samples but are not suitable for non-polyadenylated RNA targets or prokaryotic RNA applications.
-
Bazedoxifene Repurposing: Inhibition of Hemozoin Formation i
2026-05-22
This study demonstrates that Bazedoxifene, a third-generation selective estrogen receptor modulator, exhibits potent antimalarial activity by inhibiting hemozoin formation in Plasmodium falciparum. The findings reveal a novel mechanism for a clinically approved SERM and support drug repurposing strategies for malaria control.
-
Bazedoxifene: Advanced SERM Strategies for Bone and Antimala
2026-05-22
Explore Bazedoxifene as a selective estrogen receptor modulator for osteoporosis and its emerging antimalarial potential. This article delivers advanced protocol insight, mechanistic clarity, and unique cross-domain analysis not found elsewhere.
-
Patient-Derived Gastric Cancer Assembloids Advance Drug Mode
2026-05-21
This study introduces a gastric cancer assembloid model integrating matched tumor organoids and autologous stromal cell subpopulations, significantly enhancing physiological relevance and drug response fidelity. The model provides a robust platform for dissecting tumor–stroma interactions and personalizing therapeutic strategies.
-
Bradykinin (BA5201): Practical Guidance for Vascular Researc
2026-05-21
Bradykinin (SKU BA5201) provides a rigorously characterized endothelium-dependent vasodilator peptide for controlled studies on vascular permeability, smooth muscle contraction, and inflammation signaling. This article details practical workflows, protocol considerations, and troubleshooting steps for researchers. Bradykinin should not be used in diagnostic or clinical applications due to its research-only designation.
-
TCAIM-Mediated Degradation of OGDH Regulates Mitochondrial M
2026-05-20
Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds and facilitates the degradation of a-ketoglutarate dehydrogenase (OGDH), revealing a novel mechanism for post-translational regulation of mitochondrial metabolism. These findings highlight a previously unrecognized layer of metabolic control with implications for mitochondrial proteostasis and disease modeling.
-
MLN4924 HCl Salt: Optimizing NEDD8-Activating Enzyme Inhibit
2026-05-20
MLN4924 HCl salt empowers researchers to dissect the neddylation pathway with precision, enabling robust investigation of protein degradation, cell cycle arrest, and viral immune evasion. This guide delivers actionable workflow enhancements and troubleshooting tips, translating landmark mechanistic insights into practical, data-driven assay design.
-
ECL Chemiluminescent Substrate Detection Kit: Hypersensitive
2026-05-19
Unlock ultra-sensitive immunoblotting with the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), designed for reliable protein detection even at low picogram levels. Streamline your Western blot workflows and troubleshoot common detection challenges with cutting-edge HRP chemiluminescence technology.
-
FGF19-ELF4 Axis Drives Colorectal Cancer Metastasis via FGFR
2026-05-19
This study uncovers how FGF19-induced overexpression of ELF4 accelerates colorectal cancer metastasis through transcriptional activation of FGFR4 and SRC. The findings highlight a clinically relevant positive feedback circuit and suggest new therapeutic strategies for metastatic colorectal cancer.
-
Hypoxia-Driven Immunometabolism in Tumor Microenvironments
2026-05-18
This review elucidates how hypoxia and metabolic reprogramming drive the formation of immunosuppressive tumor microenvironments (TME). The authors systematically detail the mechanisms by which altered glucose metabolism and immune cell adaptations foster tumor progression, highlighting potential targets for metabolism-based cancer therapies.
-
Sitagliptin Phosphate Monohydrate: Precision DPP-4 Inhibitor
2026-05-18
Harness Sitagliptin phosphate monohydrate for breakthrough metabolic disease research with robust, reproducible protocols. This article bridges innovative gastrointestinal mechanosensation studies with advanced incretin modulation assays, delivering troubleshooting guidance and actionable protocol parameters for translational investigators.
-
Cyclosporin A: Molecular Precision and Assay Design in Immun
2026-05-17
Explore the molecular specificity of Cyclosporin A in T-cell inhibition, with a focus on cyclophilin targeting, mitochondrial regulation, and advanced assay design. Gain insights into practical protocols and recent discoveries that refine immunosuppression research.
-
Revisiting Sumatriptan Metabolism: CYP and MAO Pathways Unve
2026-05-16
This article reviews the recent study by Pöstges and Lehr, which challenges the prevailing view that sumatriptan is metabolized solely by MAO A, demonstrating that cytochrome P450 enzymes also play a role. The findings have implications for understanding serotonergic drug metabolism and may inform future research using sodium channel blockers and 5-HT inhibitors such as Lamotrigine.
-
BFH772 (VEGFR2 inhibitor): Technical Use and Protocol Guidan
2026-05-15
BFH772 is a highly selective VEGFR2 inhibitor designed for researchers investigating VEGFR2-mediated angiogenesis, with particular application in tumor model systems. It should not be used in protocols requiring water solubility or broad-spectrum kinase inhibition due to its defined selectivity and solubility profiles.
-
Puromycin Aminonucleoside: Beyond Podocyte Models—Precision
2026-05-15
Explore the advanced scientific underpinnings and translational impact of puromycin aminonucleoside in nephrotoxicity research. This article uniquely dissects its mechanistic roles, assay optimization, and bridges to cutting-edge EMT research, establishing a new benchmark for utilizing this aminonucleoside moiety in renal pathology studies.